Market Value9,648,757,562
Total Holdings93
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCRX / BioCryst Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
KOD / Kodiak Sciences Inc.
LPTX / Leap Therapeutics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
SAGE / Sage Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
INCY / Incyte Corporation
ACAD / ACADIA Pharmaceuticals Inc.
PRLD / Prelude Therapeutics Incorporated
REPL / Replimune Group, Inc.
SGMT / Sagimet Biosciences Inc.
CLDX / Celldex Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
IMTX / Immatics N.V.
RLAY / Relay Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CMPX / Compass Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
IDYA / IDEAYA Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
NGNE / Neurogene Inc.
RVMD / Revolution Medicines, Inc.
CERS / Cerus Corporation
SERA / Sera Prognostics, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
TLIS / Talis Biomedical Corporation
AVTE / Aerovate Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AKRO / Akero Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
GBIO / Generation Bio Co.
SRZNW / Surrozen, Inc. - Equity Warrant
PRME / Prime Medicine, Inc.
KRYS / Krystal Biotech, Inc.
KALA / KALA BIO, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
MRSN / Mersana Therapeutics, Inc.
FHTX / Foghorn Therapeutics Inc.
IONS / Ionis Pharmaceuticals, Inc.
SMMT * / Summit Therapeutics Inc.
ABCL / AbCellera Biologics Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
HOOK / HOOKIPA Pharma Inc.
RARE / Ultragenyx Pharmaceutical Inc.
US457669AB50 / INSMED INC CONV 0.75% 06/01/2028
ALGS / Aligos Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
ALKS / Alkermes plc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
IPSC / Century Therapeutics, Inc.
TCRX / TScan Therapeutics, Inc.
ALEC / Alector, Inc.
PMVP / PMV Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
PFE / Pfizer Inc.
MIRM / Mirum Pharmaceuticals, Inc.
ARVN / Arvinas, Inc.
BMEA / Biomea Fusion, Inc.
ATHA / Athira Pharma, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
NRIX / Nurix Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
STOK / Stoke Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
EWTX / Edgewise Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
WVE / Wave Life Sciences Ltd.
ALMS / Alumis Inc.
ROIV / Roivant Sciences Ltd.
XENE / Xenon Pharmaceuticals Inc.
ACRV / Acrivon Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
MRUS / Merus N.V.
XNCR / Xencor, Inc.
DNLI / Denali Therapeutics Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
CELC / Celcuity Inc.
BCAX / Bicara Therapeutics Inc.
VTVT / vTv Therapeutics Inc.
OPT / Opthea Limited - Depositary Receipt (Common Stock)
CTNM / Contineum Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
SKYE / Skye Bioscience, Inc.
DSGN / Design Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.